Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS)

ClinicalTrials.gov ID: NCT02954458

Public ClinicalTrials.gov record NCT02954458. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 8:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Open-label, Long-term Safety and Efficacy Study of Teduglutide in Pediatric Patients With Short Bowel Syndrome Who Completed TED-C14-006 or SHP633-301

Study identification

NCT ID
NCT02954458
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Shire
Industry
Enrollment
61 participants

Conditions and interventions

Interventions

  • TED Drug
  • SOC Other
  • Syringe Device
  • Needle Device

Drug · Other · Device

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 8, 2017
Primary completion
Nov 4, 2020
Completion
Nov 4, 2020
Last update posted
Mar 27, 2025

2017 – 2020

United States locations

U.S. sites
15
U.S. states
12
U.S. cities
14
Facility City State ZIP Site status
Childrens Hospital Los Angeles - RHU Los Angeles California 90027-6062
Mattel Children's Hospital UCLA Los Angeles California 90095
UCSF Benioff Children's Hospital San Francisco California 94158-2531
Georgetown Children's Research Network Washington D.C. District of Columbia 20007
Riley Hospital for Children Indianapolis Indiana 46202
Boston Children's Hospital Boston Massachusetts 02115
The Nebraska Medical Center Omaha Nebraska 68198
Columbia Unversity Medical Center New York New York 07024
Children's Hosp. at Montefiore The Bronx New York 10467-2403
Duke Medical Center Durham North Carolina 27710
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
Texas Children's Hospital Houston Texas 77030
Seattle Children's Hospital Seattle Washington 98105
University of Wisconsin School of Medicine and Public Health Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02954458, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 27, 2025 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02954458 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →